目录肽产品
SOMA-011B
DOTA-(Tyr3)-Octreotate\n
4,7,10-Tricarboxymethyl-1,4,7,10-tetraaza-cyclododecan-1-yl-acetyl-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr (Disulfide bond) \nAcetate salt
4,7,10-Tricarboxymethyl-1,4,7,10-tetraaza-cyclododecan-1-yl-acetyl-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr (Disulfide bond) \nAcetate salt
Size：5
P1(RMB)：6162
MW：1435.65
One letter sequence：DOTA-fCYwKTCT\n(Cys & Cys bridge)
Molecular Formula：C65H90N14O19S2
Description：DOTA-conjugated somatostatin analog for labeling with radiometals such as gallium-67 or gallium-68, indium-111, and yttrium-90. Potentially useful for receptor-mediated tumor imaging and peptide receptor-targeted radionuclide therapy.
Literature Reference：W.A.Breeman et al., Eur. J. Nucl. Med. Mol. Imaging, 30, 917 (2003)\nA.Capello et al., Cancer Biother. Radiopharm., 18, 761 (2003)\nM.de Jong et al., J. Nucl. Med., 46, 13S (2005)\nL.Kolby et al., Br. J. Cancer, 93, 1144 (2005)\nR.Valkema et al., J. Nucl. Med., 46, 83S (2005)
Cas：177943-89-4
P1(RMB)：6162
MW：1435.65
One letter sequence：DOTA-fCYwKTCT\n(Cys & Cys bridge)
Molecular Formula：C65H90N14O19S2
Description：DOTA-conjugated somatostatin analog for labeling with radiometals such as gallium-67 or gallium-68, indium-111, and yttrium-90. Potentially useful for receptor-mediated tumor imaging and peptide receptor-targeted radionuclide therapy.
Literature Reference：W.A.Breeman et al., Eur. J. Nucl. Med. Mol. Imaging, 30, 917 (2003)\nA.Capello et al., Cancer Biother. Radiopharm., 18, 761 (2003)\nM.de Jong et al., J. Nucl. Med., 46, 13S (2005)\nL.Kolby et al., Br. J. Cancer, 93, 1144 (2005)\nR.Valkema et al., J. Nucl. Med., 46, 83S (2005)
Cas：177943-89-4
-
ADD杭州市钱塘区12号大街69号
-
TEL0571-86737011
-
E-mailsales@chinesepeptide.com
Copyright © 2024 js3983线路检测生化有限公司 All Rights Reserved.
浙ICP备05051877号-1
业务咨询和客户服务
企业微信公众号
